202 related articles for article (PubMed ID: 34799559)
1. Spatial transcriptomics reveals gene expression characteristics in invasive micropapillary carcinoma of the breast.
Lv J; Shi Q; Han Y; Li W; Liu H; Zhang J; Niu C; Gao G; Fu Y; Zhi R; Wu K; Li S; Gu F; Fu L
Cell Death Dis; 2021 Nov; 12(12):1095. PubMed ID: 34799559
[TBL] [Abstract][Full Text] [Related]
2. Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma.
Wang XX; Liu BB; Wu X; Su D; Zhu Z; Fu L
Pathol Oncol Res; 2015 Sep; 21(4):1021-6. PubMed ID: 25813822
[TBL] [Abstract][Full Text] [Related]
3. Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and Predicts a Poor Prognosis.
Wu K; Li W; Liu H; Niu C; Shi Q; Zhang J; Gao G; Sun H; Liu F; Fu L
Am J Pathol; 2023 Sep; 193(9):1267-1283. PubMed ID: 37301537
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast.
Shi Q; Shao K; Jia H; Cao B; Li W; Dong S; Liu J; Wu K; Liu M; Liu F; Zhou H; Lv J; Gu F; Li L; Zhu S; Li S; Li G; Fu L
Nat Commun; 2022 Jan; 13(1):111. PubMed ID: 35013309
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of LEF1 and β-Catenin in Invasive Micropapillary Carcinoma of the Breast is Associated With Lymphovascular Invasion and Lymph Node Metastasis.
Dolezal D; Zhang X; Harigopal M
Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):557-565. PubMed ID: 35960138
[TBL] [Abstract][Full Text] [Related]
7. The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients.
Li W; Jia H; Wang S; Guo X; Zhang X; Zhang L; Wen HY; Fu L
Ann Diagn Pathol; 2022 Dec; 61():152047. PubMed ID: 36156357
[TBL] [Abstract][Full Text] [Related]
8. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast.
Meng F; Liu B; Xie G; Song Y; Zheng X; Qian X; Li S; Jia H; Zhang X; Zhang L; Yang YL; Fu L
Breast Cancer Res Treat; 2017 Nov; 166(2):383-392. PubMed ID: 28755148
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
[TBL] [Abstract][Full Text] [Related]
11. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
Guo XJ; Chen L; Lang RG; Fan Y; Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
[TBL] [Abstract][Full Text] [Related]
13. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Sakamoto DG; Takeshima Y; Inai K
Breast Cancer; 2006; 13(1):58-63. PubMed ID: 16518063
[TBL] [Abstract][Full Text] [Related]
14. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
16. [PSCA expression in invasive micropapillary carcinoma of breast].
Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
[TBL] [Abstract][Full Text] [Related]
17. Invasive Micropapillary Carcinoma of the Breast: An Update.
Yang YL; Liu BB; Zhang X; Fu L
Arch Pathol Lab Med; 2016 Aug; 140(8):799-805. PubMed ID: 27472238
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between colorectal adenocarcinoma with invasive micropapillary carcinoma component and lymph node metastasis].
Tang T; Zhang XJ; Zhao LZ; Cao YJ; Xiao L; Wang RL
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):525-9. PubMed ID: 24246917
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
[TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
